Estrogen-mediated protection against HIV Tat protein-induced inflammatory pathways in human vascular endothelial cells

Cardiovascular Research

Volumn 63, Issue 1, 2004, Pages 139-148

  Lee, Yong Woo ^a   Eum, Sung Yong ^a   Nath, Avindra ^b   Toborek, Michal ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Atherosclerosis; Cytokines; Estrogens; Gene expression; Infection inflammation

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ESTRADIOL; ESTROGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR; VASCULAR CELL ADHESION MOLECULE 1; VIRUS PROTEIN;

ARTICLE; CELL ADHESION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA BINDING; ENDOTHELIUM CELL; EXPOSURE; GEL MOBILITY SHIFT ASSAY; HEART PROTECTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; INFLAMMATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE; VASCULAR ENDOTHELIUM;

CELL ADHESION; CHEMOKINE CCL2; CYTOKINES; DNA; E-SELECTIN; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESTRADIOL; GENE EXPRESSION; GENE PRODUCTS, TAT; HIV-1; HUMANS; INTERLEUKIN-1; NF-KAPPA B; PROTEIN BINDING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; VASCULAR CELL ADHESION MOLECULE-1;

EID: 2942579250     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2004.03.006     Document Type: Article

References (51)

1. Centers for Disease Control and Prevention (CDC) Advancing HIV prevention: new strategies for a changing epidemic. MMWR. 52:2003;329-332
2. Hutchinson J.F. The biology and evolution of HIV. Annu. Rev. Anthropol. 30:2001;85-108
3. Williams K.C., Hickey W.F. Central nervous system damage, monocytes and macrophages, and neurological disorders in AIDS. Annu. Rev. Neurosci. 25:2002;537-562
4. Krishnaswamy G., Chi D.S., Kelly J.L., et al. The cardiovascular and metabolic complications of HIV infection. Cardiol. Rev. 8:2000;260-268
5. Barbaro G. Cardiovascular manifestations of HIV infection. Circulation. 106:2002;1420-1425
6. Panther L.A. How HIV infection and its treatment affect the cardiovascular system: what is known, what is needed. Am. J. Physiol. Heart Circ. Physiol. 283:2002;H1-H4
7. Tabib A., Leroux C., Mornex J.F., Loire R. Accelerated coronary atherosclerosis and arteriosclerosis in young human-immunodeficiency-virus- positive patients. Coron. Artery Dis. 11:2000;41-46
8. Stein J.H., Klein M.A., Bellehumeur J.L., et al. Use of human immunodeficiency virus-1 protease inhibitors is associated with atherogenic lipoprotein changes and endothelial dysfunction. Circulation. 104:2001;257-262
9. Frankel A.D., Young J.A. HIV-1: fifteen proteins and an RNA. Annu. Rev. Biochem. 67:1998;1-25
10. Sawaya B.E., Thatikunta P., Denisova L., et al. Regulation of TNF-α and TGFβ-1 gene transcription by HIV-1 Tat in CNS cells. J. Neuroimmunol. 87:1998;33-42
11. Chen P., Mayne M., Power C., Nath A. The Tat protein of HIV-1 induces tumor necrosis factor-α production. Implications for HIV-1-associated neurological diseases. J. Biol. Chem. 272:1997;22385-22388
12. Bruce-Keller A.J., Barger S.W., Moss N.I., et al. Pro-inflammatory and pro-oxidant properties of the HIV protein Tat in a microglial cell line: attenuation by 17β-estradiol. J. Neurochem. 78:2001;1315-1324
13. Toborek M., Lee Y.W., Pu H., et al. HIV-Tat protein induces oxidative and inflammatory pathways in brain endothelium. J. Neurochem. 84:2003;169-179
14. Pu H., Flora G., Lee Y.W., et al. HIV-1 Tat protein upregulates inflammatory mediators and induces monocyte invasion into the brain. Mol. Cell. Neurosci. 24:2003;224-237
15. Wassertheil-Smoller S., Hendrix S.L., Limacher M., et al. Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial. JAMA. 289:2003;2673-2684
16. Beral V., Banks E., Reeves G. Evidence from randomized trials on the long-term effects of hormone replacement therapy. Lancet. 360:2002;942-944
17. Lee S.J., McEwen B.S. Neurotrophic and neuroprotective actions of estrogens and their therapeutic implications. Annu. Rev. Pharmacol. Toxicol. 41:2001;569-591
18. Menon K.V., Angulo P., Boe G.M., Lindor K.D. Safety and efficacy of estrogen therapy in preventing bone loss in primary biliary cirrhosis. Am. J. Gastroenterol. 98:2003;889-892
19. Grady D., Rubin S.M., Petitti D.B., et al. Hormone therapy to prevent disease and prolong life in post menopausal women. Ann. Intern. Med. 117:1992;1016-1037
20. Nathan L., Chaudhuri G. Estrogens and atherosclerosis. Annu. Rev. Pharmacol. Toxicol. 37:1997;477-515
21. Stevenson J.C. Long-term effects of hormone replacement therapy. Lancet. 361:2003;253-254
22. Kannel W.B., Hjortland M.C., McNamara P.M., Gordon T. Menopause and risk of cardiovascular disease: the Framingham study. Ann. Intern. Med. 85:1976;447-452
23. Peters H.W., Westendorp I.C.D., Hak A.E., et al. Menopausal status and risk factors for cardiovascular disease. J. Intern. Med. 246:1999;521-528
24. Stampfer M.J., Colditz G.A., Willett W.C., et al. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study. N. Engl. J. Med. 325:1991;756-762
25. Wolf P.H., Madans J.H., Finucane F.F., Higgins M., Kleinman J.C. Reduction of cardiovascular disease-related mortality among postmenopausal women who uses hormones: evidence from a national cohort. Am. J. Obstet. Gynecol. 164:1991;489-494
26. Kushwaha R.S., Hazzard W.R. Exogenous estrogens attenuate dietary hypercholesterolemia and atherosclerosis in the rabbit. Metabolism. 30:1981;359-366
27. Negre-Salvayre A., Pieraggi M.T., Mabile L., Salvayre R. Protective effect of 17β-estradiol against the cytotoxicity of minimally oxidized LDL to cultured bovine aortic endothelial cells. Atherosclerosis. 99:1993;207-217
28. Toborek M., Lee Y.W., Kaiser S., Hennig B. Measurement of inflammatory properties of fatty acids in human endothelial cells. Redox cell biology and genetics. Methods in Enzymology. vol. 352:2002;198-219 Academic Press, New York
29. World Medical Association Declaration of Helsinki Recommendations guiding physicians in biomedical research involving human subjects. Cardiovasc. Res. 35:1997;2-3
30. Ma M., Nath A. Molecular determinants for cellular uptake of Tat protein of human immunodeficiency virus type 1 in brain cells. J. Virol. 71:1997;2495-2499
31. Jones M., Olafson K., Del Bigio M.R., Peeling J., Nath A. Intraventricular injection of human immunodeficiency virus type 1 (HIV-1) Tat protein causes inflammation, gliosis, apoptosis, and ventricular enlargement. J. Neuropathol. Exp. Neurol. 57:1998;563-570
32. Stanimirovic D., Zhang W., Howlett C., Lemieux P., Smith C. Inflammatory gene transcription in human astrocytes exposed to hypoxia: roles of the nuclear factor-κ and autocrine stimulation. J. Neuroimmunol. 119:2001;365-376
33. Meagher L., Mahiouz D., Sugars K., et al. Measurement of mRNA for E-selectin, VCAM-1 and ICAM-1 by reverse transcription and polymerase chain reaction. J. Immunol. Methods. 175:1994;237-246
34. Ballester A., Velasco A., Tobena R., Alemany S. Cot kinase activates tumor necrosis factor-α gene expression in a cyclosporin A-resistant manner. J. Biol. Chem. 273:1988;14099-14106
35. -ΔΔCT method. Methods. 25:2001;402-408
36. Deng X., Li H., Tang Y.W. Cytokine expression in respiratory syncytial virus-infected mice as measured by quantitative reverse-transcriptase PCR. J. Virol. Methods. 107:2003;141-146
37. Braut-Boucher F., Pichon J., Rat P., et al. A non-isotopic, highly sensitive, fluorimetric, cell-cell adhesion microplate assay using calcein AM-labeled lymphocytes. J. Immunol. Methods. 178:1995;41-51
38. Beg A.A., Finco T.S., Nantermet P.V., Baldwin A.S. Jr. Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of IκB alpha: a mechanism for NF-κB activation. Mol. Cell. Biol. 13:1993;3301-3310
39. Ross R. Atherosclerosis is an inflammatory disease. Am. Heart J. 138:1999;S419-S420
40. Reape T.J., Groot P.H. Chemokines and atherosclerosis. Atherosclerosis. 147:1999;213-225
41. Davies M.J., Gordon J.L., Gearing A.J., et al. The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM, and E-selectin in human atherosclerosis. J. Pathol. 171:1993;223-229
42. Lee Y.W., Son K.W., Flora G., et al. Methamphetamine activates DNA binding of specific redox-responsive transcription factors in mouse brain. J. Neurosci. Res. 70:2002;82-89
43. Lee Y.W., Hennig B., Toborek M. Redox-regulated mechanisms of IL-4-induced MCP-1 expression in human vascular endothelial cells. Am. J. Physiol. Heart Circ. Physiol. 284:2003;H185-H192
44. Kumar A., Manna S.K., Dhawan S., Aggarwal B.B. HIV-Tat protein activates c-Jun N-terminal kinase and activator protein-1. J. Immunol. 161:1998;776-781
45. Bruce-Keller A.J., Keeling J.L., Keller J.N., et al. Antiinflammatory effects of estrogen on microglial activation. Endocrinology. 141:2000;3646-3656
46. Hayashi T., Yamada K., Esaki T., et al. Estrogen increases endothelial nitric oxide by a receptor mediated system. Biochem. Biophys. Res. Commun. 214:1995;847-855
47. MacRitchie A.N., Jun S.S., Chen Z., et al. Estrogen upregulates endothelial nitric oxide synthase gene expression in fetal pulmonary artery endothelium. Circ. Res. 81:1997;355-362
48. Widder J., Pelzer T., von Poser-Klein C., et al. Improvement of endothelial dysfunction by selective estrogen receptor-alpha stimulation in ovariectomized SHR. Hypertension. 214:2003;991-996
49. Dinarello C.A. The biological properties of interleukin-1. Eur. Cytokine Netw. 5:1994;517-531
50. Galea E., Santizo R., Feinstein D.L., et al. Estrogen inhibits NF-κB-dependent inflammation in brain endothelium without interfering with IκB degradation. NeuroReport. 13:2002;1469-1472
51. Simoncini T., Maffei S., Basta G., et al. Estrogens and glucocorticoids inhibit endothelial vascular cell adhesion molecule-1 expression by different transcriptional mechanisms. Circ. Res. 87:2000;19-25